BFM
CASM

Boothbay Fund Management’s CAS Medical Systems, Inc. CASM Stock Holding History

Boothbay Fund Management’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14,066
Closed -$27K – 1027
2018
Q2 		$27K Buy
+14,066
New +$21K ﹤0.01% 720

Other funds holding CASM

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's CASM Position: Q3 2018 in Review

Boothbay Fund Management sold out of CAS Medical Systems, Inc. (CASM) in Q3 2018, closing a stake of 14,066 shares — an estimated $27K sold.

Boothbay Fund Management first reported a position in CASM in Q2 2018 and held it in 1 quarter. The position peaked at $27K in Q2 2018. 24 funds tracked by Wall St. Rank hold CASM as of Q3 2018.

  • Boothbay Fund Management reported no remaining CAS Medical Systems, Inc. position as of Q3 2018 after selling out during the quarter.
  • Boothbay Fund Management sold 14,066 CAS Medical Systems, Inc. shares in Q3 2018, an estimated $27K.
  • Boothbay Fund Management first reported a position in CAS Medical Systems, Inc. in Q2 2018 and held it in 1 quarter.
  • Boothbay Fund Management's CAS Medical Systems, Inc. position peaked at $27K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q3 2018.

Based on Boothbay Fund Management's 13F filing for Q3 2018, filed 14 Nov 2018.